Hap Trading, LLC Myovant Sciences Ltd. Put Options Transaction History

Hap Trading, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	BUY	$11.6 - $20.44 $182,120 - $320,908	15,700 New	15,700 $10,000
Q2 2021 Aug 11, 2021	SELL	$17.07 - $24.56 $199,719 - $287,352	-11,700 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$20.46 - $25.18 $159,588 - $196,404	-7,800 Reduced 40.0%	11,700 $28,000
Q4 2020 Feb 16, 2021	BUY	$13.8 - $27.62 $92,460 - $185,054	6,700 Added 52.34%	19,500 $11,000
Q1 2020 May 08, 2020	BUY	$6.55 - $14.76 $83,840 - $188,928	12,800 New	12,800 $29,000

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.